Inhibitors of Trypanosoma cruzi Sir2 related protein 1 as potential drugs against Chagas disease.
Chagas disease remains one of the most neglected diseases in the world despite being the most important parasitic disease in Latin America. The characteristic chronic manifestation of chagasic cardiomyopathy is the region's leading cause of heart-related illness, causing significant mortality a...
Main Authors: | Luís Gaspar, Ross P Coron, Paul KongThoo Lin, David M Costa, Begoña Perez-Cabezas, Joana Tavares, Meritxell Roura-Ferrer, Isbaal Ramos, Céline Ronin, Louise L Major, Fabrice Ciesielski, Iain K Pemberton, Jane MacDougall, Paola Ciapetti, Terry K Smith, Anabela Cordeiro-da-Silva |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS Neglected Tropical Diseases |
Online Access: | http://europepmc.org/articles/PMC5794198?pdf=render |
Similar Items
-
The crystal structure of the Leishmania infantum Silent Information Regulator 2 related protein 1: Implications to protein function and drug design.
by: Céline Ronin, et al.
Published: (2018-01-01) -
Meiotic sex in Chagas disease parasite Trypanosoma cruzi
by: Philipp Schwabl, et al.
Published: (2019-09-01) -
Chagas disease: Importance of rats as reservoir hosts of Trypanosoma cruzi (Chagas, 1909) in western Mexico
by: Gumercindo G. Rosal, et al.
Published: (2018-03-01) -
Histopathologic identification of Trypanosoma cruzi (Chagas') encephalitis in an AIDS patient
by: Dimath Alyemni, et al.
Published: (2017-03-01) -
THE ROLE OF IMMUNOLOGY IN COMBATING TRYPANOSOMA CRUZI INFECTION AND CHAGAS DISEASE
by: Rick L. Tarleton
Published: (2013-01-01)